About us

We develop technology for improving the care and life quality of our
most vulnerable patients – preterm born infants.

A word from Hanna Sjöström CEO

GPX Medical has set the foundation towards commercialization of a unique system for lung monitoring of preterm born infants, with great potential on the international market for medical devices. With our system we are able to improve the care of our most vulnerable patients and reduce the need for potentially harmful x-ray examinations and invasive blood tests.

Contact Hanna Sjöström, CEO
Email: hs@gpxmedical.se
Mobile: +46 (0)760 107116

Hanna Sjöström

Hanna Sjöström

CEO

The Board

Märta Lewander Xu


Märta Lewander Xu


PhD

CEO Gasporox AB

Tore Gimse

Tore Gimse

Chairman Gasporox AB and
GPX Medical AB
CEO Norsk Elektro Optikk AS

Katarina Svanberg

Katarina Svanberg

MD, PhD
Professor of Oncology
Lund University Hopspital

 

Lina Boresson

Lina Boresson

Business advisor
LifeScience
SmiLe Incubator, Ideon

Stephan Dymling

Stephan Dymling

CTO CLS AB
CTO, member of board,
BiBB Instrument
 AB

For Investors

GPX Medical is on a journey to create better care for for our most vulnerable patients.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to GASPOROX AB (publ), with the aim to develop and commercialize medical applications of GASMAS technology. The company is owned to 60% by GASPOROX AB (publ) and to 40% by Norsk Elektro Optikk AS, and located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Maskinvägen 1
223 70 Lund
Sweden
info@gpxmedical.se